Aquabounty Technologies (AQB) Raised to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of Aquabounty Technologies (NASDAQ:AQB) from a sell rating to a hold rating in a report released on Thursday morning.

According to Zacks, “AquaBounty Technologies, Inc. is a biotechnology company. It focused on enhancing productivity in aquaculture. The company operates primarily in Maynard, Massachusetts and Fortune, Prince Edward Island. AquaBounty Technologies, Inc. is based in Maynard, United States. “

Separately, HC Wainwright started coverage on Aquabounty Technologies in a report on Thursday, June 28th. They set a buy rating and a $3.75 price objective for the company.

Shares of AQB opened at $2.82 on Thursday. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.36 and a quick ratio of 3.30. Aquabounty Technologies has a 52 week low of $2.25 and a 52 week high of $9.99.

Aquabounty Technologies (NASDAQ:AQB) last issued its quarterly earnings data on Tuesday, August 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.03). The business had revenue of $0.05 million during the quarter, compared to analysts’ expectations of $0.02 million. sell-side analysts forecast that Aquabounty Technologies will post -0.78 EPS for the current fiscal year.

A hedge fund recently raised its stake in Aquabounty Technologies stock. ARK Investment Management LLC grew its stake in shares of Aquabounty Technologies Inc (NASDAQ:AQB) by 81.1% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 170,697 shares of the company’s stock after purchasing an additional 76,458 shares during the period. ARK Investment Management LLC owned about 1.33% of Aquabounty Technologies worth $568,000 as of its most recent filing with the SEC. 62.42% of the stock is currently owned by institutional investors and hedge funds.

About Aquabounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc and changed its name to AquaBounty Technologies, Inc in June 2004.

See Also: Using the New Google Finance Tool

Get a free copy of the Zacks research report on Aquabounty Technologies (AQB)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Aquabounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aquabounty Technologies and related companies with's FREE daily email newsletter.

Leave a Reply